B:

Sijia Li1, Yuanyuan Pan1, Ruyu Ye1

  • 1Department of Hematology, The Second Hospital of Dalian Medical University, Dalian, PR China.

PubMed
概括

新的癌症免疫疗法针对CTLA-4,PD-1和LAG-3等免疫检查点. 虽然目前的抑制剂显示出前景,但探索像TIGIT和TIM-3这样的新目标为有效的淋巴瘤治疗提供了新的希望.